Beta adrenergic blockers – Carvedilol MCQs With Answer
Carvedilol is a nonselective beta adrenergic blocker with additional alpha-1 blockade and antioxidant properties widely used in hypertension, heart failure, and post-MI management. This concise, student-focused introduction highlights carvedilol’s mechanism, pharmacokinetics, clinical indications, adverse effects, dosing principles, and important drug interactions to help B. Pharm students master core concepts. Emphasis on carvedilol’s hepatic metabolism, first-pass effect, impact on heart rate and afterload, and precautions in asthma and diabetes makes the content clinically relevant. This resource is optimized for revision and exam preparation. Now let’s test your knowledge with 50 MCQs on this topic.
Q1. Which of the following best describes carvedilol’s receptor activity?
- Selective β1 blocker only
- Nonselective β1/β2 blocker with α1 blockade
- α2 agonist with β1 selectivity
- Calcium channel blocker
Correct Answer: Nonselective β1/β2 blocker with α1 blockade
Q2. Which pharmacological effect of carvedilol contributes most to reduced afterload?
- β1 blockade reducing heart rate
- Antioxidant activity
- α1 blockade causing vasodilation
- Negative inotropy
Correct Answer: α1 blockade causing vasodilation
Q3. Carvedilol is particularly beneficial in systolic heart failure because it:
- Increases myocardial oxygen demand
- Improves left ventricular ejection fraction and reduces mortality
- Acts as a diuretic to remove fluid overload
- Stimulates β2 receptors to increase contractility
Correct Answer: Improves left ventricular ejection fraction and reduces mortality
Q4. The primary route of metabolism for carvedilol is:
- Renal excretion of unmetabolized drug
- Hepatic metabolism with extensive first-pass effect
- Hydrolysis in plasma
- Metabolism by gut bacteria only
Correct Answer: Hepatic metabolism with extensive first-pass effect
Q5. Which adverse effect is most likely when carvedilol is given to a patient with reactive airway disease?
- Severe hypokalemia
- Bronchospasm due to β2 blockade
- Excessive diuresis
- Hyperglycemia unmasking
Correct Answer: Bronchospasm due to β2 blockade
Q6. Which of the following is a common initial dose for carvedilol in chronic heart failure?
- 50 mg once daily
- 3.125 mg twice daily
- 100 mg once daily
- 0.5 mg once daily
Correct Answer: 3.125 mg twice daily
Q7. Carvedilol’s antioxidant properties are thought to:
- Directly increase heart rate
- Reduce oxidative stress and myocardial remodeling
- Cause immediate diuresis
- Block ACE receptors
Correct Answer: Reduce oxidative stress and myocardial remodeling
Q8. Which monitoring parameter is most important after initiating carvedilol therapy?
- Serum amylase
- Heart rate and blood pressure
- Serum magnesium
- Pupillary size
Correct Answer: Heart rate and blood pressure
Q9. Carvedilol may mask signs of hypoglycemia in diabetic patients by:
- Enhancing insulin secretion
- Blunting sympathetic symptoms such as tachycardia
- Increasing hepatic gluconeogenesis
- Stimulating pancreatic alpha cells
Correct Answer: Blunting sympathetic symptoms such as tachycardia
Q10. Which patient condition is an absolute contraindication to carvedilol?
- Compensated hypothyroidism
- Symptomatic bradycardia and cardiogenic shock
- Controlled hypertension on ACE inhibitors
- Mild hepatic steatosis
Correct Answer: Symptomatic bradycardia and cardiogenic shock
Q11. Compared with selective β1 blockers, carvedilol’s nonselective β blockade may increase the risk of:
- Peripheral vasodilation only
- Bronchoconstriction in susceptible patients
- Hyperreflexia
- Enhanced insulin sensitivity exclusively
Correct Answer: Bronchoconstriction in susceptible patients
Q12. Which formulation difference exists for carvedilol preparations?
- Only intramuscular forms are available
- Immediate-release tablets and extended-release (CR) tablets are available
- Only topical cream formulation exists
- Only IV infusion form is used chronically
Correct Answer: Immediate-release tablets and extended-release (CR) tablets are available
Q13. Carvedilol’s effect on cardiac remodeling is primarily due to:
- Direct diuretic action
- Neurohormonal blockade and antioxidant effects
- Stimulation of sympathetic outflow
- Calcium influx enhancement
Correct Answer: Neurohormonal blockade and antioxidant effects
Q14. Which lab change may be seen with beta blocker therapy like carvedilol?
- Marked leukocytosis
- Masked tachycardia during hypoglycemia
- Elevated serum lipase in all patients
- Rapid increase in hemoglobin
Correct Answer: Masked tachycardia during hypoglycemia
Q15. Which pharmacokinetic property explains carvedilol’s variable oral bioavailability?
- Poor intestinal absorption only
- Extensive hepatic first-pass metabolism
- Complete renal clearance
- Immediate conversion to active metabolites in stomach
Correct Answer: Extensive hepatic first-pass metabolism
Q16. In acute decompensated heart failure, initiating carvedilol is:
- Recommended as first-line immediately
- Usually avoided until patient is hemodynamically stable
- Mandatory at high doses
- Contraindicated forever thereafter
Correct Answer: Usually avoided until patient is hemodynamically stable
Q17. Which of the following effects does carvedilol have on insulin sensitivity and lipid profile in some studies?
- Always causes severe hyperglycemia
- May have neutral or modestly favorable metabolic effects compared with some β blockers
- Only worsens lipid profile dramatically
- Acts as an insulin secretagogue
Correct Answer: May have neutral or modestly favorable metabolic effects compared with some β blockers
Q18. Which drug interaction is most clinically important with carvedilol?
- Concurrent use with nitrates causing alkalosis
- Use with other negative chronotropes (e.g., verapamil) increasing risk of bradycardia
- Antacids enhancing carvedilol effects
- Vitamin C reducing carvedilol clearance
Correct Answer: Use with other negative chronotropes (e.g., verapamil) increasing risk of bradycardia
Q19. Which statement about carvedilol’s half-life is correct?
- Extremely short (< 30 minutes)
- Approximately 7–10 hours allowing twice-daily dosing for immediate release
- Several days, allowing once-weekly dosing
- Indefinite accumulation with single dose
Correct Answer: Approximately 7–10 hours allowing twice-daily dosing for immediate release
Q20. Which physiological response to sympathetic stimulation is directly blocked by carvedilol?
- Sweating mediated by muscarinic receptors
- β1-mediated increase in heart rate and contractility
- Growth hormone secretion
- Vitamin D activation
Correct Answer: β1-mediated increase in heart rate and contractility
Q21. Which clinical trial outcome is associated with carvedilol therapy in heart failure?
- No change in mortality
- Reduced mortality and fewer hospitalizations
- Immediate cure of heart failure
- Universal prevention of myocardial infarction
Correct Answer: Reduced mortality and fewer hospitalizations
Q22. When switching from another β blocker to carvedilol, a pharmacist should advise:
- No dose adjustment is ever required
- Gradual titration and careful monitoring for hypotension and bradycardia
- Stop other medications permanently
- Double the carvedilol dose on the first day
Correct Answer: Gradual titration and careful monitoring for hypotension and bradycardia
Q23. Carvedilol’s vasodilating action primarily results in:
- Increased afterload
- Decreased systemic vascular resistance
- Increased pulmonary artery pressure
- Enhanced platelet aggregation
Correct Answer: Decreased systemic vascular resistance
Q24. Which adverse effect is most commonly reported with carvedilol initiation?
- Transient dizziness and hypotension
- Immediate renal failure in all patients
- Severe hyperthermia
- Profound hyperkalemia universally
Correct Answer: Transient dizziness and hypotension
Q25. In which post-myocardial infarction scenario is carvedilol indicated?
- To increase heart rate after MI
- To reduce sympathetic drive and improve survival when clinically appropriate
- To immediately dissolve thrombus
- To replace reperfusion therapy
Correct Answer: To reduce sympathetic drive and improve survival when clinically appropriate
Q26. Which statement about carvedilol and renal impairment is correct?
- No dose adjustment is needed in all stages of renal failure
- Use caution; carvedilol is mainly hepatically cleared but monitor clinical response
- It is cleared exclusively by dialysis
- It is contraindicated in any renal impairment
Correct Answer: Use caution; carvedilol is mainly hepatically cleared but monitor clinical response
Q27. Which side effect may limit carvedilol use in the elderly?
- Excessive stimulation and insomnia
- Orthostatic hypotension and dizziness
- Increased appetite leading to weight gain only
- Marked hyperactivity
Correct Answer: Orthostatic hypotension and dizziness
Q28. Which of the following is a pharmacodynamic consequence of blocking β2 receptors with carvedilol?
- Bronchodilation
- Bronchoconstriction and potential worsening of asthma
- Activation of renin secretion
- Increased glycogenolysis only
Correct Answer: Bronchoconstriction and potential worsening of asthma
Q29. Which of the following best describes carvedilol’s effect on heart rate variability and sympathetic tone?
- Increases sympathetic tone
- Reduces sympathetic activity and can improve heart rate variability
- Has no effect on autonomic balance
- Causes permanent autonomic failure
Correct Answer: Reduces sympathetic activity and can improve heart rate variability
Q30. Which monitoring is most relevant when titrating carvedilol in heart failure patients?
- Pulmonary function tests weekly
- Blood pressure, heart rate, and signs of worsening heart failure
- Daily liver biopsy
- Routine EEG monitoring
Correct Answer: Blood pressure, heart rate, and signs of worsening heart failure
Q31. Which of the following is an appropriate counseling point for carvedilol tablets?
- Stop carvedilol abruptly once symptoms improve
- Take with food to reduce orthostatic hypotension and improve absorption
- Never take with water
- Take only at bedtime without regard to food
Correct Answer: Take with food to reduce orthostatic hypotension and improve absorption
Q32. Which effect on lipid profile has been reported with some β blockers but is less pronounced with carvedilol?
- Increase in HDL universally
- Adverse changes in triglycerides and HDL
- Complete normalization of LDL
- Immediate reduction in blood glucose
Correct Answer: Adverse changes in triglycerides and HDL
Q33. Which pharmacokinetic factor may increase carvedilol plasma concentrations?
- Drugs that inhibit hepatic metabolism (CYP inhibitors)
- Enhanced renal clearance only
- Concurrent high-fiber diet always
- Taking with grapefruit-free juice exclusively
Correct Answer: Drugs that inhibit hepatic metabolism (CYP inhibitors)
Q34. Which of the following adverse effects may improve with continued carvedilol therapy over weeks?
- Bradycardia always resolves
- Initial fatigue and dizziness may lessen as the body adapts
- Permanent impotence resolves immediately
- Severe hypotension persists indefinitely
Correct Answer: Initial fatigue and dizziness may lessen as the body adapts
Q35. Which statement about carvedilol’s use in hypertension is correct?
- It is ineffective for blood pressure control
- It lowers blood pressure via β blockade and α1-mediated vasodilation
- It exclusively acts as a central α2 agonist
- It raises blood pressure when combined with diuretics
Correct Answer: It lowers blood pressure via β blockade and α1-mediated vasodilation
Q36. Which patient should receive carvedilol with caution or not at all?
- Patient with well-controlled diabetes and no COPD
- Patient with active bronchospasm and severe reactive airway disease
- Patient taking a statin for hyperlipidemia
- Patient with seasonal allergies only
Correct Answer: Patient with active bronchospasm and severe reactive airway disease
Q37. Carvedilol’s negative inotropic effect means:
- It increases the force of myocardial contraction
- It decreases myocardial contractility
- It increases stroke volume in all patients
- It exclusively affects skeletal muscle
Correct Answer: It decreases myocardial contractility
Q38. Which is a sign of excessive β-blockade that patients should be instructed to report?
- Tachycardia and palpitations
- Dizziness, marked bradycardia, or syncope
- Increased appetite with weight gain only
- Improved exercise tolerance suddenly
Correct Answer: Dizziness, marked bradycardia, or syncope
Q39. Which statement about carvedilol dosing frequency is accurate for the immediate-release formulation?
- Once-weekly dosing is standard
- Usually given twice daily due to its half-life
- Requires administration every hour
- Only a single dose at bedtime is recommended
Correct Answer: Usually given twice daily due to its half-life
Q40. Which therapeutic benefit distinguishes carvedilol from pure β1-selective blockers?
- Alpha-1 blockade causing vasodilation and afterload reduction
- Exclusive renal vasodilation only
- Direct activation of β2 receptors
- It is a potent diuretic
Correct Answer: Alpha-1 blockade causing vasodilation and afterload reduction
Q41. Which adverse metabolic effect should be watched for with carvedilol in diabetic patients?
- Unmasked hyperthyroidism
- Masking of hypoglycemic symptoms such as tachycardia
- Immediate insulin overproduction
- Permanent increase in fasting glucose in all patients
Correct Answer: Masking of hypoglycemic symptoms such as tachycardia
Q42. Which statement about carvedilol and pregnancy is correct?
- It is the preferred antihypertensive in pregnancy without any risk
- Use requires a risk-benefit assessment; β blockers may have fetal effects
- It increases fertility and is indicated for conception
- It is absolutely contraindicated in all pregnant women
Correct Answer: Use requires a risk-benefit assessment; β blockers may have fetal effects
Q43. Which organ system is primarily responsible for carvedilol elimination?
- Renal excretion of unchanged drug
- Hepatic metabolism followed by biliary excretion
- Lung exhalation
- Pancreatic secretion
Correct Answer: Hepatic metabolism followed by biliary excretion
Q44. Which feature of carvedilol contributes to improved clinical outcomes in heart failure compared with placebo?
- Improved myocardial oxygen consumption and neurohormonal modulation
- Increased cardiac workload
- Only symptomatic cough improvement
- Guaranteed reversal of ischemic lesions
Correct Answer: Improved myocardial oxygen consumption and neurohormonal modulation
Q45. What is the effect of abrupt withdrawal of carvedilol after chronic therapy?
- No clinical consequence
- Risk of rebound hypertension and angina; gradual tapering is recommended
- Immediate life-long immunity to sympathetic activity
- Instant conversion to ACE inhibitor effect
Correct Answer: Risk of rebound hypertension and angina; gradual tapering is recommended
Q46. Which dosing strategy is appropriate when uptitrating carvedilol in heart failure?
- Begin at a high target dose immediately
- Start low and titrate slowly as tolerated to target doses
- Increase dose only if blood pressure becomes very low
- Do not change dose after initial administration
Correct Answer: Start low and titrate slowly as tolerated to target doses
Q47. Which symptom suggests carvedilol overdose?
- Marked bradycardia and hypotension
- Excessive thirst only
- Improved mental acuity
- Hyperactivity and tremor
Correct Answer: Marked bradycardia and hypotension
Q48. Which co-prescribed drug class requires caution because of additive negative chronotropic effects with carvedilol?
- Loop diuretics
- Non-dihydropyridine calcium channel blockers (e.g., verapamil, diltiazem)
- H2 blockers only
- Topical antifungals
Correct Answer: Non-dihydropyridine calcium channel blockers (e.g., verapamil, diltiazem)
Q49. Which clinical effect would suggest therapeutic benefit of carvedilol in a heart failure patient over weeks to months?
- Worsening exercise tolerance
- Improved ejection fraction and decreased hospitalization frequency
- Rapid increase in heart rate
- New onset severe cough requiring cessation
Correct Answer: Improved ejection fraction and decreased hospitalization frequency
Q50. Which patient counseling point is correct regarding missed doses of carvedilol?
- If you miss a dose, double the next dose
- If you miss a dose, take it as soon as remembered unless it is almost time for the next dose
- Skip all future doses for 3 days
- Stop medication permanently after one missed dose
Correct Answer: If you miss a dose, take it as soon as remembered unless it is almost time for the next dose
